[How to follow-up on the recommendations of the ESH/ESC guidelines for different kinds of blood pressure measurement methods].
Better understanding of epidemiology and pathophysiology of arterial hypertension has resulted in new definitions of blood pressure levels and treatment targets. The main reason for worldwide modest outcomes in the treatment of hypertension is suboptimal drug treatment including incomplete dose titration and an inadequate antihypertensive drug combinations. New techniques such as teletransmission of home blood pressure measurement together with ambulant 24-hour-blood-pressure-monitoring could serve as a solution to provide the physician the opportunity for an adequate antihypertensive therapy, in order to improve drug compliance and to shorten the time until reaching optimal blood pressure.
Schulz
E G
EG
Nephrologisches Zentrum Göttingen, Universitätsspital Zürich, Germany. eg.schulz@goedia.de
Battegay
E
E
Neumann
L
L
Schmidt-Weitmann
S
S
Brockes
C
C
D047228:Angiotensin II Type 1 Receptor Blockers / Q000627:therapeutic use; D000959:Antihypertensive Agents / Q000627:therapeutic use*; D001713:Biphenyl Compounds / Q000627:therapeutic use; D001794:Blood Pressure / Q000187:drug effects; D018660:Blood Pressure Monitoring, Ambulatory / Q000295:instrumentation / Q000379:methods*; D040421:Cell Phone / Q000295:instrumentation; D004305:Dose-Response Relationship, Drug; D004359:Drug Therapy, Combination; D006801:Humans; D006973:Hypertension / Q000175:diagnosis / Q000188:drug therapy*; D000077405:Irbesartan; D055118:Medication Adherence; D017410:Practice Guidelines as Topic; D016032:Randomized Controlled Trials as Topic; D012016:Reference Values; D012984:Software; D013686:Telemetry / Q000295:instrumentation; D013777:Tetrazoles / Q000627:therapeutic use; D016896:Treatment Outcome
D047228:Angiotensin II Type 1 Receptor Blockers; D000959:Antihypertensive Agents; D001713:Biphenyl Compounds; D013777:Tetrazoles; D000077405:Irbesartan